Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024 10

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024 10

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024 13

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024 13

Secret vulnerabilities of cancer's 'Death Star' protein revealed

byCenter for Genomic RegulationA three-dimensional image showing the human protein KRAS (blue) interacting with RAF1 (yellow), one of its main partners. The blue-to-red colour gradient indicates

Updated on: December 30,2023 9

Secret vulnerabilities of cancer's 'Death Star' protein revealed

byCenter for Genomic RegulationA three-dimensional image showing the human protein KRAS (blue) interacting with RAF1 (yellow), one of its main partners. The blue-to-red colour gradient indicates

Updated on:December 30,2023 9

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on: December 28,2023 10

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on:December 28,2023 10

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on: January 12,2024 10

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on:January 12,2024 10

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on: March 20,2024 16

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on:March 20,2024 16

Researcher recommends tailoring colorectal cancer screening for 45-to-49-year-olds

by Regenstrief InstituteCredit: Pixabay/CC0 Public DomainIt's been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for

Updated on: January 30,2024 20

Researcher recommends tailoring colorectal cancer screening for 45-to-49-year-olds

by Regenstrief InstituteCredit: Pixabay/CC0 Public DomainIt's been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for

Updated on:January 30,2024 20

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on: December 28,2023 9

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on:December 28,2023 9

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on: January 04,2024 8

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on:January 04,2024 8

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on: January 23,2024 20

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on:January 23,2024 20

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on: January 02,2024 9

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on:January 02,2024 9

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on: January 30,2024 15

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on:January 30,2024 15